Compare HCM & AMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HCM | AMC |
|---|---|---|
| Founded | 2000 | 1920 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | 2015 | 2007 |
| Metric | HCM | AMC |
|---|---|---|
| Price | $13.52 | $2.50 |
| Analyst Decision | Sell | Hold |
| Analyst Count | 1 | 4 |
| Target Price | ★ $13.75 | $2.03 |
| AVG Volume (30 Days) | 81.4K | ★ 18.6M |
| Earning Date | 03-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,848,900,000.00 |
| Revenue This Year | $20.60 | $11.41 |
| Revenue Next Year | $15.62 | $5.18 |
| P/E Ratio | $5.49 | ★ N/A |
| Revenue Growth | N/A | ★ 4.57 |
| 52 Week Low | $9.77 | $0.93 |
| 52 Week High | $17.79 | $3.18 |
| Indicator | HCM | AMC |
|---|---|---|
| Relative Strength Index (RSI) | 63.47 | 49.37 |
| Support Level | $12.99 | $2.32 |
| Resistance Level | $15.54 | $3.00 |
| Average True Range (ATR) | 0.29 | 0.15 |
| MACD | 0.13 | -0.02 |
| Stochastic Oscillator | 68.12 | 16.06 |
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. The company owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.